SCHEMBL17878015

SCHEMBL17878015

CCOC(=O)C1CCN(c2ccc(CNC(=O)OC(C)(C)C)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.57
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
TSHR P16473 1/20 0.57
MAPT P10636 2/20 0.55
LGMN Q99538 2/20 0.54
HPGD P15428 6/20 0.49
F10 P00742 3/20 0.49
ITGB3 P05106 3/20 0.49
PRSS1 P07477 3/20 0.49
PRSS2 P07478 3/20 0.49
ITGA2B P08514 3/20 0.49
PRSS3 P35030 3/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
CYP2C19 P33261 2/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
POLB P06746 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29192701 0.90 MAPT (0.52) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL17878013 0.86 SMN1; SMN2 (0.49) ALDH1A1MEN1KMT2AMAPTF10
SCHEMBL26101401 0.84 SMN1; SMN2 (0.51) MEN1KMT2AMAPTSMN1; SMN2CYP2C19
SCHEMBL29311592 0.82 CKS1B (0.53) MEN1KMT2AMAPTF10SMN1; SMN2
SCHEMBL23582690 0.81 MAPT (0.56) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL20946394 0.81 KMT2A (0.55) ALDH1A1MEN1KMT2AMAPTHPGD
SCHEMBL17878014 0.81 SMN1; SMN2 (0.46) ALDH1A1MEN1KMT2AMAPTSMN1; SMN2
SCHEMBL7379963 0.81 MAPT (0.60) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL26648305 0.80 ALDH1A1 (0.50) ALDH1A1MEN1KMT2ATSHRMAPT
SCHEMBL21396291 0.80 SMN1; SMN2 (0.54) MEN1KMT2AMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160185774-A1 Anti-Infective Compounds INSTITUT PASTEUR KOREA (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160185774-A1 Anti-Infective Compounds RABGGTB, ELANE, SERPINB1 ALDH1A1 3932/4885MEN1 3685/4885KMT2A 4781/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.